Skip to content
BidBenchmark
Special NoticeAmendment 2

Intent to Sole Source - Untargeted Metabolomics Analysis

NATIONAL INSTITUTES OF HEALTH · Bethesda, Maryland, 20892

Response status

Historical record

Aug 31, 2026, 4:00 PM UTC

This notice is no longer open.

Posted
Aug 21, 2026
Archive date
Sep 15, 2026
SAM status
Active
This is a preserved solicitation record. The response window is closed because the published deadline passed.

Answer-first brief

What the source record says

  • NATIONAL INSTITUTES OF HEALTH published this special notice.
  • Competition is listed as No Set aside used.
  • The place of performance is Bethesda, Maryland.
  • The notice uses NAICS 541380 (Testing Laboratories and Services).

Procurement identity

Notice ID
916aa510d7ce4aa38655622f4aae2308
Solicitation
NOI-OLAO-CC-26-008751
Base type
Special Notice
Version
2 of 2

Solicitation facts

Structured fields from the current SAM notice version. A dash means the source did not publish a value.

Notice type
Special Notice
Solicitation number
NOI-OLAO-CC-26-008751
Set-aside
No Set aside used
Set-aside code
Posted
Aug 21, 2026
Responses due
Aug 31, 2026, 4:00 PM UTC
Archive date
Sep 15, 2026
Archive type
auto15
Base type
Special Notice
Organization type
AGENCY
Benchmark category
Category confidence
Category source
Last seen
Sep 5, 2026

Buyer and place

Office hierarchy and place of performance as published.

Department
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Department code
Subagency
National Institutes of Health
Subagency code
Office
NATIONAL INSTITUTES OF HEALTH
Organization path
Organization path codes
Office address
Bethesda, MD, 20892, US
Place of performance
Bethesda, Maryland, 20892
City code
State
Maryland
State code
MD
Postal code
20892
Country

Notice description

Source text reproduced without an AI summary.

This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Metabolon, Inc. Acquisition Description: The TBHP Branch (TBHP) requests the purchase of a contract for Metabolon, Inc., to perform untargeted metabolomics analysis of human fecal samples. The materials will be used in a collaborative protocol between the NIH Clinical Center TBHP Branch, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Heart, Lung, and Blood Institute to quantify and compare microbiome-derived metabolites and dietary xenobiotics in diets primarily consisting of unprocessed and ultra-processed food to investigate metabolic pathways altered by ultra-processed diets. The metabolomics analysis needs to be able to: Detect and quantify a broad panel of small-molecule metabolites (including dietary xenobiotics and microbiota-derived compounds) in fecal samples Enable simultaneous analysis of a large array of cytokines, chemokines, and metabolites in small sample volumes Interface with Thermo Fisher Scientific Luminex platforms for downstream immune/metabolic biomarker analysis Provide comprehensive untargeted metabolite coverage validated for use with human fecal samples. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-008751) by 12:00 PM eastern standard time on 08/31/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Comparable award range

Historical award values for work matched by the fixed rubric—not an estimate of this opportunity.

Low end (p25)$17,107
Median$37,485
High end (p75)$121,626
Comparable awards
50
Median
$37,485
Computed
Aug 24, 2026
Rubric
comparables@2026.08.1
Comparable award values describe completed contracts. They do not state the government's budget and are not a bid recommendation.

Comparable awards

The match score is decomposed so each comparison can be challenged.

AwardContractorValueAwardedScoreWhy it matched
SENTINEL BIOLOGICAL SAMPLE TESTINGVRL MARYLAND LLC$35,365.50May 4, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
ACCREDITATIONS ASSESSMENT SERVICES EO 14398AMERICAN ASSOCIATION FOR LABORATORY ACCREDITATION$4,300.00Jun 22, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
ACCREDITATION OF CBERS LABORATORY QUALITY SYSTEM AND REFERENCE MATERIALS PRODUCTIONAMERICAN ASSOCIATION FOR LABORATORY ACCREDITATION$46,155.00Jul 6, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
GENETIC SERVICESTRANSNETYX, INC$31,966.00May 11, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
EO14398 SUPPLY SURVEY MATERIALS AND TEST SERVICE EVALUATIONS OPTION 2COLLEGE OF AMERICAN PATHOLOGISTS$267,978.59Jul 24, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
GENERATION OF TRANSGENIC MOUSE MODELS (GRNA DESIGN, ORDER AND VALIDATION)WASHINGTON UNIVERSITY, THE$15,806.08Jul 16, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
DNA EXTRACTION SERVICES (IMMUNOSEQ)ADAPTIVE BIOTECHNOLOGIES CORPORATION$20,700.00Sep 15, 202160Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
FY26 UDO INITIATIVE RNA SEQUENCING SERVICESPSOMAGEN INC$23,750.00May 21, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
FY26 UDO INITIATIVE *COVID-19* RNA ISOLATION, DNA GENERATION, LIBRARY PREPARATIONPSOMAGEN INC$9,460.00Apr 22, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
FY26 UDO INITIATIVE ANALYSIS OF 860 DE-IDENTIFIED PLASMA SAMPLES FOR DONTHE JOHNS HOPKINS UNIVERSITY$67,988.00May 21, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
FY26 UDO INITIATIVE: CUSTOM GENE SYNTHESIS AND EXPRESSIONGENSCRIPT USA INC$17,209.00May 21, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
FY 2026 UDO INITIATIVE - THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FUNDS.PSOMAGEN INC$17,004.00May 18, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
FY26 UDO INITIATIVE FISHER BIOSERVICES, INC (AMBIS #2216704) TESTING LABORATORIES AND STORFISHER BIOSERVICES INC$15,378.24May 6, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
FY26 UDO INITIATIVE PRECISION ANTIBODY (AMBIS #2229539) LAB TESTING, FUSION, CLONINGA&G PHARMACEUTICAL, INC.$15,500.00Apr 22, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
BULK RNA AND SINGLE CELL RNA SEQUENCINGTHE JOHNS HOPKINS UNIVERSITY$18,721.00Jun 17, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
ANALYSIS OF THE ROLE OF MITOCHONDRIAL GENETIC VARIATION IN DEMENTIATHE JOHNS HOPKINS UNIVERSITY$280,561.00Apr 23, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
NIA LAB REQUIRES SERVICE TO PERFORM MASS SPECTROMETRY IN CONTROL, ANALYZE, AND COMPARE THEMS BIOWORKS LLC$25,200.00Apr 17, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
NHLBI: SERVICE: OLINK EXPLORE HT PROTEOMIC ANALYSIS FOR SEPSIS BIOMARKER STUDY: SEVERABLEPSOMAGEN INC$48,777.00May 14, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
NHLBI: SERVICE: OLINK EXPLORE HT PROTEOMIC ANALYSIS FOR SICKLE CELL DISEASE STUDY: SEVERABPSOMAGEN INC$199,994.72May 14, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)
NULISA (A NOVEL PROTEOMIC LIQUID BIOPSY PLATFORM WITH ATTOMOLAR SENSITIVITY AND HIGH MULTIBANNER HEALTH$2,332,200.00Jun 24, 202660Same product and service code (25), Same industry code (20), Same place of performance (8), Recent enough to be relevant (7)

Amendment history

A version is preserved whenever the normalized notice contents change.

VersionNotice typeObservedResponses dueContent hash
1Special NoticeAug 23, 2026Aug 31, 2026, 4:00 PM UTC4f31946a5629e885
2Special NoticeAug 28, 2026Aug 31, 2026, 4:00 PM UTC6070bc35dc31c9a5

Record provenance

Field-level lineage for the current opportunity version.

FieldSourceSource as ofParserTransform
agency_nameSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_dateSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_typeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
base_typeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
city_nameSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
country_codeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
descriptionSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
naics_codeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_idSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_typeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_citySAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_country_codeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_nameSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_postal_codeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_state_codeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
organization_typeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
pop_postal_codeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
posted_dateSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
psc_codeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
response_deadlineSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
sam_urlSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
set_aside_label_rawSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
solicitation_numberSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
state_codeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
subagency_nameSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
titleSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3
upstream_activeSAM.gov Contract OpportunitiesAug 23, 2026sam_opportunity_snapshot@2026.08.22026.08.3

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

Comparable awards are scored on benchmark category, product and service code, industry code, buyer, place, recency, and contract type. Rubric version comparables@2026.08.1.

  1. 1Notice fields come from the SAM.gov contract opportunities record last seen Sep 5, 2026. SAM.gov remains authoritative.
  2. 2Computed from 50 completed federal awards using comparables@2026.08.1, as of Aug 24, 2026. Award values are neither unit prices nor a forecast.

Note 1 covers the solicitation record; note 2 covers the comparable range. No synthetic FAQ or inferred solicitation value is published.

Intent to Sole Source - Untargeted Metabolomics Analysis — federal contract opportunity · BidBenchmark